Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06379035 | Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients | unknown | — | 54 | Assiut UniversityOTHER | 0 | Apr 23, 2024 | clinicaltrials |
| NCT03935763 | Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective(PROMETCO) | unknown | — | 738 | Servier Affaires MédicalesINDUSTRY | 18 | Apr 22, 2024 |
| NCT03579784 | Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer | unknown | Phase 2 | 40 | Do-Youn OhOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04298008 | AZD6738 Plus Durvalumab in Biliary Tract Cancer | unknown | Phase 2 | 26 | Seoul National University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04298021 | DDR-Umbrella Study of DDR Targeting Agents in Advanced Biliary Tract Cancer | unknown | Phase 2 | 74 | Seoul National University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer(NaliCap) | unknown | Phase 2 | 200 | Seoul National University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04447092 | Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer | unknown | Phase 2 | 77 | Seoul National University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT04727996 | Phase II Study of Sitravatinib in Combination With Tislelizumab in Patients With Advanced Biliary Tract Cancer(BTC-BGB) | unknown | Phase 2 | 43 | Seoul National University HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06375434 | Correlation Between Gut Microbiota and Radiosensitivity of Rectal Cancer(GMRSC-LARC) | unknown | — | 100 | Jing-kun LiuOTHER | 0 | Apr 19, 2024 | clinicaltrials |
| NCT06375486 | Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）. | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT06375642 | A Single Arm, Single Centered Phase II Trial on the Combination of Adebrelimab, Surufatinib and Irinotecan Liposome-based HAIC in Advanced iCC | unknown | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT03732105 | Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)(RAISE) | unknown | N/A | 148 | Sun Yat-sen UniversityOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT06006026 | The Safety of Ropivacaine TAP Block Combined With Intravenous Lidocaine in Patients Undergoing Colorectal Cancer Surgery | unknown | N/A | 9 | West China HospitalOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04104230 | Quebec Pancreas Cancer Study(QPCS) | unknown | — | 2,000 | George ZogopoulosOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04318834 | Molecular Profiling of Advanced Biliary Tract Cancers(COMPASS-B-MUHC) | unknown | N/A | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05129046 | Neutrophil-to-Lymphocite Ratio (NLR) and C-reactive Protein (CRP) as New Markers in Diagnosis and Prediction of Colorectal Cancer(NelyCre) | unknown | — | 100 | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di AlessandriaOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05661357 | Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression(HCCSC-C03) | unknown | Phase 4 | 51 | Zhongnan HospitalOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06028516 | MRD Application in Colorectal Cancer Patients | unknown | — | 200 | Shandong First Medical UniversityOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06233864 | A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer | unknown | Phase 2 | 63 | Sun Yat-sen UniversityOTHER | 0 | Apr 17, 2024 | clinicaltrials |
| NCT06369480 | Prognostic Factors for Survival in Patients With Cholangiocarcinoma | unknown | — | 2,000 | Rigshospitalet, DenmarkOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06369597 | A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery | unknown | N/A | 177 | Sun Yat-sen UniversityOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06370065 | Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) Patients | unknown | Phase 2 | 35 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT03962088 | Timisnar - Biomarkers Substudy (Timisnar-mirna)(TiMiSNAR-miRNA) | unknown | — | 200 | Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di AlessandriaOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT06366685 | Development and Initial Application of a Combined Exercise and Psychological Intervention Program for Patients After Esophagectomy(Recovery) | unknown | N/A | 60 | Mengmeng YuanOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04908813 | Study of HLX22 in Combanition With Trastuzumab and Chemotherapy Versus Placebo in Combination With Trastuzumab and Chemotherapy for Treatment of Locally Advanced or Metastatic Gastric Cancer | unknown | Phase 2 | 150 | Shanghai Henlius BiotechINDUSTRY | 1 | Apr 15, 2024 | clinicaltrials |
| NCT05181488 | Intraoperative Radiation Therapy for Resectable Pancreatic Cancer | unknown | N/A | 80 | Yona ChoOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06365034 | Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular Carcinoma | unknown | — | 92 | Qianfoshan HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06014372 | Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | unknown | Phase 2 | 55 | Sun Yat-sen UniversityOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06061445 | Radiotherapy Combined With TKI and Anti-PD-1 Antibody for Stage IIIA Hepatocellular Carcinoma | unknown | N/A | 22 | Fujian Cancer HospitalOTHER_GOV | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06079554 | Microbiota and Metabolomics of Intestinal Type of Gastric Cancer | unknown | — | 32 | Jilin UniversityOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06362070 | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy | unknown | N/A | 75 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06362902 | Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer | unknown | N/A | 37 | National Cancer Center, ChinaOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363552 | A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer | unknown | Phase 2 | 36 | Tianshu LiuOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06364007 | HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCC | unknown | Phase 2 | 20 | Sulai LiuOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT05519605 | Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD(BESTDRAIN) | unknown | — | 61 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06186089 | Effect of Gastrectomy on Gut Microbiome and Cognitive Function | unknown | — | 45 | Jiangjiang BiOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT06354036 | Transhiatal Tunnel Valvuloplasty for Reconstruction Following the Laparoscopic Proximal Gastrectomy | unknown | N/A | 30 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT06356623 | A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer | unknown | — | 476 | Shanghai Zhongshan HospitalOTHER | 0 | Apr 10, 2024 | clinicaltrials |
| NCT04677244 | Echo-endoscopy Biopsy Impact on the Circulating Tumor Cell Level(EUS-CTC) | unknown | N/A | 42 | Institut Paoli-CalmettesOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06139926 | Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors | unknown | Phase 3 | 126 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06353581 | Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX | unknown | Phase 2 | 78 | Yonsei UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06355700 | Hepatocellular Carcinoma Liver Organoids(HELIO) | unknown | N/A | 10 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06351384 | Early Detection and Risk Stratification of Colorectal Cancer Based on miRNA Platform | unknown | — | 600 | Sir Run Run Shaw HospitalOTHER | 0 | Apr 8, 2024 | clinicaltrials |
| NCT05064618 | Investigator-initiated Clinical Trial of MIKE-1(MIKE-1) | unknown | Phase 1 / Phase 2 | 55 | Nagoya UniversityOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06347198 | Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer | unknown | Early Phase 1 | 30 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT03721744 | A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer | unknown | Phase 2 / Phase 3 | 336 | 1Globe Health Institute LLCINDUSTRY | 3 | Apr 3, 2024 | clinicaltrials |
| NCT05314946 | Nutritional Support During Induction Therapy for Esophageal Cancer | unknown | N/A | 26 | Mehdi QiabiOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06343272 | Lymphocyte Enhancement in Gastroenteric Oncology | unknown | N/A | 54 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | Apr 3, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 23, 2024source: clinicaltrials